| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |